Early access to antiretroviral therapy versus standard of care among HIV‐positive participants in Eswatini in the public health sector: the MaxART stepped‐wedge randomized controlled trial

INTRODUCTION: The WHO recommends antiretroviral treatment (ART) for all HIV‐positive patients regardless of CD4 count or disease stage, referred to as “Early Access to ART for All” (EAAA). The health systems effects of EAAA implementation are unknown. This trial was implemented in a government‐manag...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Shaukat, Spiegelman, Donna, Walsh, Fiona, Mazibuko, Sikhatele, Pasipamire, Munyaradzi, Chai, Boyang, Reis, Ria, Mlambo, Khudzie, Delva, Wim, Khumalo, Gavin, Zwane, Mandisa, Fleming, Yvette, Mafara, Emma, Hettema, Anita, Lejeune, Charlotte, Chao, Ariel, Bärnighausen, Till, Okello, Velephi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507004/
https://www.ncbi.nlm.nih.gov/pubmed/32949103
http://dx.doi.org/10.1002/jia2.25610

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507004/
https://www.ncbi.nlm.nih.gov/pubmed/32949103
http://dx.doi.org/10.1002/jia2.25610

Ejemplares similares